Last reviewed: June 25, 2026

Last updated: June 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Many men considering weight loss wonder whether adding testosterone replacement therapy (TRT) to a GLP-1 medication like Wegovy is safe or effective. Both medications influence metabolism, appetite, and cardiovascular function, so understanding their interaction is essential before starting either treatment. PlexusDx provides clinically supervised semaglutide therapy tailored to your unique metabolic profile, helping you navigate treatment decisions with medical guidance.

Start your GLP-1 program with PlexusDx

One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.

Start your intake →

How Semaglutide and Testosterone Affect Weight Loss Differently

Semaglutide works by mimicking glucagon-like peptide-1 (GLP-1), a hormone that reduces hunger signals and slows stomach emptying. Clinical trials show semaglutide reduces body weight by 15–22% over 68 weeks in people with obesity. Testosterone therapy, by contrast, primarily influences lean muscle mass, metabolic rate, and fat distribution—it does not directly suppress appetite the way GLP-1 agonists do.

When testosterone levels are low, men often experience weight gain, fatigue, and reduced muscle retention. Restoring healthy testosterone levels can improve body composition and energy for exercise. However, testosterone alone rarely produces the dramatic weight loss seen with semaglutide, because it does not reduce caloric intake. Combining both medications may address different metabolic pathways, but this requires careful monitoring by a qualified healthcare provider.

Safety Concerns When Combining Wegovy and Testosterone

Both semaglutide and testosterone can influence cardiovascular risk factors, including blood pressure, heart rate variability, and lipid profiles. Testosterone therapy may increase hematocrit (red blood cell concentration) and can elevate blood pressure in some patients. Semaglutide has been associated with rare but serious pancreatitis and can affect gastrointestinal motility. When used together, these effects may be amplified, particularly in men with existing hypertension, heart disease, or a personal history of pancreatitis.

Drug-drug interactions between semaglutide and testosterone are not extensively documented in major clinical trials, partly because most GLP-1 studies exclude men on active TRT. This evidence gap means any combination requires individualized medical assessment, not a standardized protocol. Your prescribing physician must review your complete medical history, current medications, and baseline cardiovascular health before approving concurrent use.

Medical Supervision and Monitoring Requirements

If you and your doctor decide that combining semaglutide with testosterone therapy is appropriate, frequent monitoring becomes non-negotiable. Baseline assessments should include blood pressure, lipid panels, liver and kidney function, fasting glucose, and hemoglobin A1c. Follow-up labs should occur at 4–6 week intervals during dose escalation and then quarterly once stable, with particular attention to pancreatic enzymes, hematocrit, and cardiovascular markers.

PlexusDx clinicians work with patients considering multiple therapies to ensure safe co-prescription and ongoing surveillance. Starting with lower semaglutide doses (0.25 mg weekly) allows you to assess tolerability before dose escalation. Your healthcare provider can adjust testosterone dosing in parallel if needed, and both medications can be paused or modified if adverse signals emerge during monitoring.

Personalized Semaglutide Therapy Starting at $189 Per Month

PlexusDx offers compounded semaglutide injections from licensed 503A compounding pharmacies, starting at just $189 per month. Your dose may need to go up as your body adjusts and you progress toward your weight loss goal—but your price won't increase. This transparent, flat-rate pricing model eliminates surprise costs and makes sustained GLP-1 therapy accessible without insurance or membership fees.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Alternative Approaches: GLP-1 Therapy Without Testosterone

For many men, addressing nutritional deficiencies, exercise consistency, and sleep quality may eliminate the need for testosterone therapy while pursuing GLP-1-based weight loss. A thorough evaluation by an endocrinologist can clarify whether low testosterone is a primary condition or a secondary consequence of obesity and poor metabolic health. In some cases, weight loss with semaglutide alone restores testosterone levels naturally.

If testosterone supplementation is genuinely needed, discussing timing with your semaglutide provider is wise. Some men benefit from stabilizing on semaglutide first (8–12 weeks), then adding testosterone under careful monitoring. Others may initiate both simultaneously under close supervision. PlexusDx clinicians can coordinate with your TRT provider to ensure seamless, safe management of both therapies.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Is it safe to take Wegovy and testosterone at the same time?

Concurrent use requires careful medical oversight because both medications influence cardiovascular function, metabolism, and blood pressure. Major clinical trials have not extensively studied this combination, so any decision must be individualized and based on your complete health history. PlexusDx clinicians can help you and your physician evaluate whether the benefits outweigh the risks in your specific case.

Will testosterone boost the weight loss effects of semaglutide?

Testosterone primarily supports lean muscle mass and metabolic rate but does not directly suppress appetite like semaglutide does. While healthy testosterone levels improve body composition and energy, semaglutide is the primary driver of weight loss in this combination. Adding testosterone may help you preserve muscle during weight loss, but it is unlikely to magnify the appetite-suppressing effects of GLP-1 therapy.

What monitoring is required if I combine these medications?

Your doctor should order baseline labs including blood pressure, lipid panels, liver and kidney function, and pancreatic markers before starting. Repeat labs at 4–6 week intervals during dose escalation, then quarterly once stable. Special attention should focus on cardiovascular markers, hematocrit, and pancreatic enzymes, given the individual risks of each medication.

Can I start semaglutide with PlexusDx if I am already on testosterone?

Yes, PlexusDx can work with you and your testosterone provider to coordinate safe initiation of semaglutide. Compounded semaglutide from PlexusDx is $189 per month month-to-month, or from $149/mo on the 6-month plan with no flat per-compound pricing increases. Your prescribing clinician will review your testosterone regimen, baseline health markers, and any prior reactions to ensure safe co-therapy.

What is the Precision Peptide Genetic Test and how does it help?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves